A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020.
- DOI
- 10.1080/20523211.2026.2673689
- Published
- 2026
- Container
- Journal of pharmaceutical policy and practice
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/20523211.2026.2673689,
title = {A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020.},
author = {Arora M and Elliott S and Kilcoyne A and Bolodeoku J and El Baghdady A},
year = {2026},
journal = {Journal of pharmaceutical policy and practice},
doi = {10.1080/20523211.2026.2673689},
url = {https://doi.org/10.1080/20523211.2026.2673689}
}RIS
TY - JOUR TI - A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020. AU - Arora M AU - Elliott S AU - Kilcoyne A AU - Bolodeoku J AU - El Baghdady A PY - 2026 JO - Journal of pharmaceutical policy and practice DO - 10.1080/20523211.2026.2673689 UR - https://doi.org/10.1080/20523211.2026.2673689 ER -
APA
M, A., S, E., A, K., J, B., & A, E. B. (2026). A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020.. Journal of pharmaceutical policy and practice. https://doi.org/10.1080/20523211.2026.2673689
Source records
- pubmed · retrieved 2026-09-26T22:49:10.876Z